Cargando…
Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy
PURPOSE: Conjugation of nanocarriers with antibodies that bind to specific membrane receptors that are overexpressed in cancer cells enables targeted delivery. In the present study, we developed and synthesised two PAMAM dendrimer-trastuzumab conjugates that carried docetaxel or paclitaxel, specific...
Autores principales: | Marcinkowska, Monika, Stanczyk, Maciej, Janaszewska, Anna, Sobierajska, Ewelina, Chworos, Arkadiusz, Klajnert-Maculewicz, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722151/ https://www.ncbi.nlm.nih.gov/pubmed/31482205 http://dx.doi.org/10.1007/s11095-019-2683-7 |
Ejemplares similares
-
Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy
por: Marcinkowska, Monika, et al.
Publicado: (2018) -
Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody
por: Marcinkowska, Monika, et al.
Publicado: (2019) -
Intrinsic Fluorescence of PAMAM Dendrimers—Quenching Studies
por: Konopka, Malgorzata, et al.
Publicado: (2018) -
Sugar Modification Enhances Cytotoxic Activity of PAMAM-Doxorubicin Conjugate in Glucose-Deprived MCF-7 Cells – Possible Role of GLUT1 Transporter
por: Sztandera, Krzysztof, et al.
Publicado: (2019) -
Cytotoxicity of Dendrimers
por: Janaszewska, Anna, et al.
Publicado: (2019)